Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer.
CONCLUSIONS: DNA methylation levels of three markers can be useful for differentiating differentiated thyroid cancer from non-malignant follicular thyroid lesions, and may serve as prognostic biomarkers for predicting recurrent or persistent disease following surgery for differentiated thyroid cancer.
PMID: 31797753 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Study | Thyroid | Thyroid Cancer